A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma (AB-218-IIT-201)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05577416 |
|
Recruitment Status :
Recruiting
First Posted : October 13, 2022
Last Update Posted : October 13, 2022
|
Sponsor:
Melbourne Health
Collaborators:
Walter and Eliza Hall Institute of Medical Research
AnHeart Therapeutics Inc.
Information provided by (Responsible Party):
Melbourne Health
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 1, 2024 |
| Estimated Study Completion Date : | December 1, 2025 |